Skip to main content

Advertisement

SpringerLink
Log in

Valve-in-valve transcatheter aortic valve implantation overcoming hostile anatomy: Evolut R for the treatment of Mitroflow bioprosthesis dysfunction

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Redo surgery is regarded as the first-line treatment option for patients presenting with prosthetic valve degeneration. However, many patients have concomitant co-morbidities and this option is associated with significant risk. Transcatheter valve-in-valve implantation is an alternative strategy depending on the bioprosthetic valve that is being treated. The Sorin Mitroflow bioprosthetic aortic valve has been regarded as a contraindication to valve-in-valve treatment due to the high risk of coronary obstruction. We here present the case of a patient with small peripheral vasculature who underwent successful transfemoral valve-in-valve implantation and subsequently discuss the challenges and technical aspects that require consideration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Brown JM, O’Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82–90.

    Article  PubMed  Google Scholar 

  2. Vesely I. The evolution of bioprosthetic heart valve design and its impact on durability. Cardiovasc Pathol. 2003;12(5):277–86.

    Article  CAS  PubMed  Google Scholar 

  3. Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87(2):521–5.

    Article  PubMed  Google Scholar 

  4. Balsam LB, Grossi EA, Greenhouse DG, Ursomanno P, Deanda A, Ribakove GH, Culliford AT, Galloway AC. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg. 2010;90(4):1195–2000 (discussion 1201).

    Article  PubMed  Google Scholar 

  5. Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35(24):1588–98.

    Article  PubMed  Google Scholar 

  6. Eggebrecht H, Schafer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Mollmann H, Baumgartner H, Carrel T, Kahlert P, et al. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011;4(11):1218–27.

    Article  PubMed  Google Scholar 

  7. Dvir D, Webb J, Brecker S, Bleiziffer S, HildickSmith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126(19):2335–44.

    Article  PubMed  Google Scholar 

  8. Dvir D, Leipsic J, Blanke P, Ribeiro HB, Kornowski R, Pichard A, Rodes-Cabau J, Wood DA, Stub D, Ben-Dor I, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv. 2015;8(1):e002079.

    Article  PubMed  Google Scholar 

  9. Gurvitch R, Cheung A, Bedogni F, Webb JG. Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv. 2011;77(3):439–44.

    Article  PubMed  Google Scholar 

  10. Bapat V, Mydin I, Chadalavada S, Tehrani H, Attia R, Thomas M. A guide to fluoroscopic identification and design of bioprosthetic valves: a reference for valve-in-valve procedure. Catheter Cardiovasc Interv. 2013;81(5):853–61.

    Article  PubMed  Google Scholar 

  11. Linke A, Woitek F, Merx MW, Schiefer C, Mobius-Winkler S, Holzhey D, Rastan A, Ender J, Walther T, Kelm M, et al. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves. Circ Cardiovasc Interv. 2012;5(5):689–97.

    Article  CAS  PubMed  Google Scholar 

  12. Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136(3):688–96.

    Article  PubMed  Google Scholar 

  13. Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, Tamburino C, Barbanti M, Chakravarty T, Jilaihawi H, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62(17):1552–62.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Raffaele Scientific Institute, Milan, Italy

    Neil Ruparelia, Antonio Colombo & Azeem Latib

  2. Imperial College, London, UK

    Neil Ruparelia

  3. EMO-GVM Centro Cuore Columbus, Via Buonarroti 48, 20145, Milan, Italy

    Neil Ruparelia, Antonio Colombo & Azeem Latib

Authors
  1. Neil Ruparelia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonio Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Azeem Latib
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Azeem Latib.

Ethics declarations

Disclosures

Dr. Azeem Latib is a consultant for Medtronic and Direct Flow Medical. Dr. Antonio Colombo is a Minor Shareholder of Direct Flow. Inc.

Human and animal informed consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Full informed consent was obtained from the patient.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruparelia, N., Colombo, A. & Latib, A. Valve-in-valve transcatheter aortic valve implantation overcoming hostile anatomy: Evolut R for the treatment of Mitroflow bioprosthesis dysfunction. Cardiovasc Interv and Ther 31, 292–295 (2016). https://doi.org/10.1007/s12928-015-0354-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-015-0354-0

Keywords

Search

Navigation